Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD

MLA

Mark J. Koury, et al. “Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.” Journal of the American Society of Nephrology, vol. 26, Oct. 2015, pp. 2578–87. EBSCOhost, https://doi.org/10.1681/asn.2014080842.

APA

Mark J. Koury, Kausik Umanath, Efrain Reisin, Khe Ni Ma, John Manley, Diana Jalal, Ebele M. Umeukeje, Jamie P. Dwyer, Mohammed Sika, Samuel S. Blumenthal, Julia B. Lewis, Barbara A. Greco, Dana G. Negoi, Robert Niecestro, Anand N. Hiremath, Tom Greene, & Steven Zeig. (2015). Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD. Journal of the American Society of Nephrology, 26, 2578–2587. https://doi.org/10.1681/asn.2014080842

Chicago

Mark J. Koury, Kausik Umanath, Efrain Reisin, Khe Ni Ma, John Manley, Diana Jalal, Ebele M. Umeukeje, et al. 2015. “Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.” Journal of the American Society of Nephrology 26 (October): 2578–87. doi:10.1681/asn.2014080842.